Trevi Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

29.06.22	Trevi Therapeutics Reports Positive Results From Phase 2b/3 PRISM Trial Of Haduvio (RTTNews)
29.06.22	Trevi Therapeutics Reports Positive Results from the Ph2b/3 PRISM Trial of Haduvio™ in the Treatment of Prurigo Nodularis (PR Newswire)
07.06.22	Trevi Therapeutics to Present and Participate in Partnership Meetings at Upcoming 2022 BIO International Convention (PR Newswire)
12.05.22	Trevi Therapeutics Announces First Quarter 2022 Financial Results and Business Update (PR Newswire)
05.05.22	Trevi Therapeutics to Report Q1 2022 Financial Results and Provide a Corporate Update on May 12, 2022 (PR Newswire)
03.05.22	Trevi Therapeutics to Present at Upcoming May Meetings (PR Newswire)
11.04.22	Trevi Therapeutics to Participate at 21st Annual Needham Virtual Healthcare Conference (PR Newswire)
07.04.22	Trevi Therapeutics Announces $55 Million Private Placement Priced At-the-Market (PR Newswire)
05.04.22	Trevi Therapeutics to Participate at 21st Annual Needham Virtual Healthcare Conference (PR Newswire)
22.03.22	Trevi Therapeutics Hosting Key Opinion Leader Webinar on the Seriousness of Chronic Cough in Idiopathic Pulmonary Fibrosis (IPF) (PR Newswire)
17.03.22	Trevi Therapeutics Announces Fourth Quarter and Year End 2021 Financial Results and Business Update (PR Newswire)
15.03.22	Trevi Therapeutics Concludes Enrollment for Phase 2 CANAL Trial in IPF Chronic Cough (PR Newswire)
09.03.22	Trevi Therapeutics to Report Q4 and Year End 2021 Financial Results and Provide a Corporate Update on March 17, 2022 (PR Newswire)
24.02.22	Trevi Therapeutics Reports Statistically Significant Result on Interim Analysis from the Ph2 CANAL Trial of Nalbuphine ER in the Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis (PR Newswire)
01.02.22	Trevi Therapeutics Completes Enrollment for Phase 2b/3 PRISM Study in Chronic Pruritus in PN (PR Newswire)
05.01.22	Trevi Therapeutics Announces Clinical Trial Updates for Lead Indications (PR Newswire)
16.12.21	Trevi Therapeutics to Attend Multiple Conferences in January 2022 (PR Newswire)
15.11.21	Trevi Therapeutics to Present at 5th Annual Dermatology Drug Development Summit for Inflammatory Skin Diseases (PR Newswire)
10.11.21	Trevi Therapeutics Announces Third Quarter 2021 Financial Results and Business Update (PR Newswire)
09.11.21	Trevi Therapeutics to Present at Stifel 2021 Virtual Healthcare Conference (PR Newswire)
03.11.21	Trevi Therapeutics to Report Q3 2021 Financial Results and Provide a Corporate Update on Wednesday, November 10, 2021 (PR Newswire)
13.10.21	Trevi Therapeutics to Present at 11th World Congress on Itch (WCI) (PR Newswire)
11.10.21	Pre-market Movers: TRVI, NTRB, LQDA, CEI, AVDL… (RTTNews)
07.10.21	Trevi Therapeutics Participating in Alliance Global Partners' Virtual Biotech & Specialty Pharma Conference (PR Newswire)
01.10.21	Trevi Therapeutics Announces $11.8 Million Private Placement Priced At-the-Market (PR Newswire)
12.08.21	Trevi Therapeutics Announces Second Quarter 2021 Financial Results and Business Update (PR Newswire)
09.08.21	Trevi Therapeutics Announces Additions to the Senior Leadership Team (PR Newswire)
05.08.21	Trevi Therapeutics to Report Q2 2021 Financial Results on August 12 (PR Newswire)
09.06.21	Trevi Therapeutics to Present at 2021 BIO Digital Conference (PR Newswire)
11.08.20	Stock Alert: Trevi Therapeutics Up 30% (RTTNews)
10.07.20	Pre-market Movers In Healthcare Sector: ANIX, BNGO, ZIOP, TRVI… (RTTNews)
08.07.20	CRVS, HEPA Jump On COVID-19 Drug Bandwagon, LVGO In Good Health, NVAX Joins $100 Stock Price Club (RTTNews)
01.04.20	EYEG Catches Eyes, KNSA & COVID-19, VVUS Gains Weight On Launch Of Telemedicine (RTTNews)
04.01.20	Will Trevi Therapeutics (TRVI) Take Off After Dismal 2019? (RTTNews)
23.12.19	Healthcare IPOs That Disappointed Investors In 2019 (RTTNews)
16.10.19	Today's Top 5 Losers In Healthcare Sector (KOOL, TRVI, OPGN…) (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Swiss Re	133.55	4.50 %	K V
Swiss Life Hldg	693.60	0.93 %	K V
Zurich Insur Gr	552.80	0.91 %	K V
Kuehne+Nagel Int	206.60	0.78 %	K V
Sonova Hldg	294.00	0.58 %	K V
Sika	228.20	-1.04 %	K V
Part Grp Hldg	1’264.50	-1.56 %	K V
Geberit	538.20	-1.61 %	K V
Alcon	75.22	-1.75 %	K V
Lonza Grp	532.80	-2.81 %	K V

Nachrichten zu Trevi Therapeutics Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten